amiodarone has been researched along with Arrhythmogenic Right Ventricular Dysplasia in 19 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Arrhythmogenic Right Ventricular Dysplasia: A congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the RIGHT VENTRICLE wall and loss of myocardial cells. Primary injuries usually are at the free wall of right ventricular and right atria resulting in ventricular and supraventricular arrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The tissue distribution of amiodarone and desethylamiodarone, its active metabolite, was examined in an autopsied case, an 85-year-old man, with arrhythmogenic right ventricular cardiomyopathy (ARVC) who had been receiving amiodarone for 4 years." | 7.71 | Amiodarone distribution in human tissues after long-term therapy: a case of arrhythmogenic right ventricular cardiomyopathy. ( Hosaka, F; Kasanuki, H; Matsuda, N; Sakomura, Y; Shiga, T; Wakaumi, M, 2002) |
| "The potential severity of amiodarone-induced hyperthyroidism, particularly in severe cardiopathy cases, necessitates a regular clinic and biologic thyroid control." | 7.71 | [Value of total thyroidectomy in amiodarone-induced hyperthyroidism]. ( Carlioz, R; Chollet, O; Dariel, MP; Gouteyron, JF; Hervé, S; Leyral, H; Perrier, E, 2001) |
| "Since amiodarone was first marketed in 1992 in Japan, the incidence of amiodarone-induced thyrotoxicosis (AIT) has been increasing." | 7.70 | Amiodarone-induced thyrotoxicosis associated with thyrotropin receptor antibody. ( Demura, H; Kanaji, Y; Kasanuki, H; Ohnishi, S; Sato, K; Yamazaki, K, 1998) |
| "The tissue distribution of amiodarone and desethylamiodarone, its active metabolite, was examined in an autopsied case, an 85-year-old man, with arrhythmogenic right ventricular cardiomyopathy (ARVC) who had been receiving amiodarone for 4 years." | 3.71 | Amiodarone distribution in human tissues after long-term therapy: a case of arrhythmogenic right ventricular cardiomyopathy. ( Hosaka, F; Kasanuki, H; Matsuda, N; Sakomura, Y; Shiga, T; Wakaumi, M, 2002) |
| "The potential severity of amiodarone-induced hyperthyroidism, particularly in severe cardiopathy cases, necessitates a regular clinic and biologic thyroid control." | 3.71 | [Value of total thyroidectomy in amiodarone-induced hyperthyroidism]. ( Carlioz, R; Chollet, O; Dariel, MP; Gouteyron, JF; Hervé, S; Leyral, H; Perrier, E, 2001) |
| "Since amiodarone was first marketed in 1992 in Japan, the incidence of amiodarone-induced thyrotoxicosis (AIT) has been increasing." | 3.70 | Amiodarone-induced thyrotoxicosis associated with thyrotropin receptor antibody. ( Demura, H; Kanaji, Y; Kasanuki, H; Ohnishi, S; Sato, K; Yamazaki, K, 1998) |
| "Arrhythmogenic right ventricular cardiomyopathy is a genetic cardiomyopathy characterized by replacement of right ventricular myocardium by fibrofatty infiltrates, leading to significant ventricular arrhythmias with sudden death and right ventricular dysfunction." | 2.50 | [Anesthetic management of patients with arrhythmogenic right ventricular cardiomyopathy]. ( Kato, Y, 2014) |
| "The ECG documented ventricular tachycardia (VT) when the patient has palpitations." | 1.38 | The presence of giant epsilon waves in a patient with arrhythmogenic right ventricular cardiomyopathy. ( Bao, H; Cheng, X; Hong, K; Li, J, 2012) |
| "Arrhythmogenic right ventricular cardiomyopathy is a desmosomal disease." | 1.37 | Guidelines for the diagnosis and management of arrhythmogenic right ventricular cardiomyopathy. ( Smith, W, 2011) |
| "Sotalol was associated with a greater risk of any clinically relevant ventricular arrhythmia as defined by sustained ventricular tachycardia or ICD therapy (hazard ratio [HR]: 2." | 1.35 | Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry. ( Cannom, DS; Estes, NA; Glidden, DV; Marcus, F; Marcus, GM; Polonsky, B; Scheinman, MM; Smith, LM; Zareba, W, 2009) |
| "We report a case of arrhythmogenic right ventricular cardiomyopathy with a right ventricular thrombus located inside a single apical aneurysm in the presence of normal right ventricular systolic function." | 1.31 | [Right ventricular thrombosis in arrhythmogenic cardiomyopathy. A case report]. ( Antonini-Canterin, F; Nicolosi, GL; Pavan, D; Sandrini, R; Zardo, F, 2000) |
| "Arrhythmogenic right ventricular dysplasia is an inherited, progressive condition." | 1.31 | Arrhythmogenic right ventricular dysplasia. An illustrated review highlighting developments in the diagnosis and management of this potentially fatal condition. ( Fisher, NG; Gilbert, TJ, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (10.53) | 18.2507 |
| 2000's | 10 (52.63) | 29.6817 |
| 2010's | 6 (31.58) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Gomes, AC | 1 |
| Lopes, LR | 1 |
| Cruz, I | 1 |
| Almeida, AR | 1 |
| Miranda, R | 1 |
| Almeida, S | 1 |
| Brandão, L | 1 |
| Pereira, H | 1 |
| Adachi, Y | 1 |
| Hayashi, T | 1 |
| Mitsuhashi, T | 1 |
| Sakakura, K | 1 |
| Yamada, Y | 1 |
| Wada, Y | 1 |
| Horie, M | 1 |
| Momomura, SI | 1 |
| Fujita, H | 1 |
| Kato, Y | 1 |
| Bruña, V | 1 |
| Díez-Villanueva, P | 1 |
| Martínez-Sellés, M | 1 |
| Datino, T | 1 |
| Fernández-Avilés, F | 1 |
| Marcus, GM | 1 |
| Glidden, DV | 1 |
| Polonsky, B | 1 |
| Zareba, W | 1 |
| Smith, LM | 1 |
| Cannom, DS | 1 |
| Estes, NA | 1 |
| Marcus, F | 1 |
| Scheinman, MM | 1 |
| Mitchell, LB | 1 |
| Pinamonti, B | 1 |
| Dragos, AM | 1 |
| Pyxaras, SA | 1 |
| Merlo, M | 1 |
| Pivetta, A | 1 |
| Barbati, G | 1 |
| Di Lenarda, A | 1 |
| Morgera, T | 1 |
| Mestroni, L | 1 |
| Sinagra, G | 1 |
| Smith, W | 1 |
| Bao, H | 1 |
| Hong, K | 1 |
| Li, J | 1 |
| Cheng, X | 1 |
| Hosaka, F | 1 |
| Shiga, T | 1 |
| Sakomura, Y | 1 |
| Wakaumi, M | 1 |
| Matsuda, N | 1 |
| Kasanuki, H | 2 |
| Khalil, SI | 1 |
| Kamal, A | 1 |
| Ahmad, S | 1 |
| Riera, M | 1 |
| Herrero, J | 1 |
| Antón, E | 1 |
| Fiol, M | 1 |
| García-Quintana, A | 1 |
| Ortega-Trujillo, JR | 1 |
| Medina Fernández-Aceytuno, A | 1 |
| Markiewicz-Łoskot, G | 1 |
| Moric-Janiszewska, E | 1 |
| Loskot, M | 1 |
| Szydłowski, L | 1 |
| Hollek, A | 1 |
| Weglarz, L | 1 |
| van Daele, ME | 1 |
| Berger, RM | 1 |
| Smeets, J | 1 |
| Hess, J | 1 |
| Sato, K | 1 |
| Yamazaki, K | 1 |
| Kanaji, Y | 1 |
| Ohnishi, S | 1 |
| Demura, H | 1 |
| Antonini-Canterin, F | 1 |
| Sandrini, R | 1 |
| Pavan, D | 1 |
| Zardo, F | 1 |
| Nicolosi, GL | 1 |
| Fisher, NG | 1 |
| Gilbert, TJ | 1 |
| Dariel, MP | 1 |
| Hervé, S | 1 |
| Chollet, O | 1 |
| Leyral, H | 1 |
| Perrier, E | 1 |
| Carlioz, R | 1 |
| Gouteyron, JF | 1 |
1 review available for amiodarone and Arrhythmogenic Right Ventricular Dysplasia
| Article | Year |
|---|---|
[Anesthetic management of patients with arrhythmogenic right ventricular cardiomyopathy].
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Amiodarone; Anesthesia, General; Anesthesia, | 2014 |
18 other studies available for amiodarone and Arrhythmogenic Right Ventricular Dysplasia
| Article | Year |
|---|---|
Arrhythmogenic Right Ventricular Cardiomyopathy: An Exuberant Case Affecting Both Ventricles.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Bundle-Branch Block; | 2020 |
Late presentation of arrhythmogenic right ventricular cardiomyopathy in an octogenarian associated with a pathogenic variant in the plakophilin 2 gene: a case report.
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; C | 2019 |
Atrioventricular Conduction Disorder as a First Manifestation of Arrhythmogenic Right Ventricular Dysplasia.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Arrhythmogenic Righ | 2016 |
Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventric | 2009 |
Empiric antiarrhythmic drug therapy in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia: pragmatism or anachronism?
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dy | 2009 |
Prognostic predictors in arrhythmogenic right ventricular cardiomyopathy: results from a 10-year registry.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Death, Sudden | 2011 |
Guidelines for the diagnosis and management of arrhythmogenic right ventricular cardiomyopathy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Defibrillators, Impl | 2011 |
The presence of giant epsilon waves in a patient with arrhythmogenic right ventricular cardiomyopathy.
Topics: Amiodarone; Arrhythmogenic Right Ventricular Dysplasia; Defibrillators, Implantable; Echocardiograph | 2012 |
Amiodarone distribution in human tissues after long-term therapy: a case of arrhythmogenic right ventricular cardiomyopathy.
Topics: Adipose Tissue; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ve | 2002 |
Arrhythmogenic right ventricular dysplasia presenting as acute coronary syndrome: a case report.
Topics: Acute Disease; Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Coron | 2004 |
[Myocarditis and arrhythmogenic dysplasia of right ventricle].
Topics: Aged; Amiodarone; Arrhythmogenic Right Ventricular Dysplasia; Bundle-Branch Block; Cardiac Pacing, A | 2006 |
[Arrhythmogenic right ventricular dysplasia in the elderly].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Electric Count | 2007 |
Arrhythmogenic right ventricular dysplasia:clinical study.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Catheter | 2007 |
[Sudden death in young persons caused by arrhythmogenic right ventricular dysplasia].
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Death, S | 1998 |
Amiodarone-induced thyrotoxicosis associated with thyrotropin receptor antibody.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Autoantibodie | 1998 |
[Right ventricular thrombosis in arrhythmogenic cardiomyopathy. A case report].
Topics: Acenocoumarol; Adult; Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Arrhythmogenic Right Ventr | 2000 |
Arrhythmogenic right ventricular dysplasia. An illustrated review highlighting developments in the diagnosis and management of this potentially fatal condition.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventric | 2000 |
[Value of total thyroidectomy in amiodarone-induced hyperthyroidism].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Emergencies; | 2001 |